Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Travere Therapeutics's Pegtibatinase?
Pegtibatinase is a recombinant enzyme commercialized by Travere Therapeutics, with a leading Phase III program in Homocystinuria. According to Globaldata,...
Pegtibatinase by Travere Therapeutics for Homocystinuria: Likelihood of Approval
Pegtibatinase is under clinical development by Travere Therapeutics and currently in Phase III for Homocystinuria. According to GlobalData, Phase III...
Risk adjusted net present value: What is the current valuation of Travere Therapeutics's Pegtibatinase?
Pegtibatinase is a recombinant enzyme commercialized by Travere Therapeutics, with a leading Phase III program in Homocystinuria. According to Globaldata,...